Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xue, L.
Right arrow Articles by Yen, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xue, L.
Right arrow Articles by Yen, Y.
[Cancer Research 63, 980-986, March 1, 2003]
© 2003 American Association for Cancer Research


Experimental Therapeutics

Wild-Type p53 Regulates Human Ribonucleotide Reductase by Protein-Protein Interaction with p53R2 as well as hRRM2 Subunits1

Lijun Xue, Bingsen Zhou, Xiyong Liu, Weihua Qiu, Zhongchu Jin and Yun Yen2

Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, California 91010 [L. X., B. Z., X. L., W. Q., Y. Y.], and Department of Pathophysiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310031, People’s Republic of China [L. X., Z. J.]

Ribonucleotide reductase (RR) plays a key role in the synthesis of DNA and is the only enzymeresponsible for the reduction of ribonucleotides to their corresponding deoxyribonucleotides, providing a balanced supply of precursors for DNA synthesis and repair. There are three known human RR subunits, hRRM1, hRRM2, and p53R2, which is encoded by a p53 target gene. It is not clear whether p53 and RR can directly interact at the protein level to regulate DNA repair. It is also not known where deoxyribonucleotides are synthesized in the cell. In coimmunoprecipitation experiments, we found that hRRM2 and p53R2, but not hRRM1, bound to p53 in KB cells, which express wild-type p53. Moreover, in response to UV irradiation, both p53R2 and hRRM2 were released from p53 and shifted to bind hRRM1. Confocal microscopy confirmed the colocalization of p53 with p53R2 and hRRM2 and the translocation of hRRM1, p53R2 and hRRM2 from the cytoplasm to the nucleus after UV treatment. An in vivo RR activity assay showed that the kinetic profile of increased RR activity was consistent with the accumulation of RR subunits in the nucleus. The ability of p53R2 and hRRM2 to shift from binding p53 to hRRM1 in response to UV irradiation was deficient in the presence of mutant p53. Moreover, in cells overexpressing hRRM2, binding of p53R2 to p53 decreased, whereas binding to hRRM1 increased. Our results suggest that wild-type p53 directly interacts with both p53R2 and hRRM2. In response to UV irradiation, p53R2 and hRRM2 dissociate from p53 and p53R2, and hRRM2 and hRRM1 transfer to the nucleus and form an active RR complex to provide dNDPs for DNA repair. Therefore, the direct interaction of p53 with p53R2 and hRRM2 and the nuclear accumulation of RR subunits after UV exposure might play a pivotal role in DNA repair.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
H.-L. Devlin, P. C. Mack, R. A. Burich, P. H. Gumerlock, H.-J. Kung, M. Mudryj, and R. W. deVere White
Impairment of the DNA Repair and Growth Arrest Pathways by p53R2 Silencing Enhances DNA Damage-Induced Apoptosis in a p53-Dependent Manner in Prostate Cancer Cells
Mol. Cancer Res., May 1, 2008; 6(5): 808 - 818.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Vujcic, M. Shroff, and K. K. Singh
Genetic Determinants of Mitochondrial Response to Arsenic in Yeast Saccharomyces cerevisiae
Cancer Res., October 15, 2007; 67(20): 9740 - 9749.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Marusyk, L. J. Wheeler, C. K. Mathews, and J. DeGregori
p53 Mediates Senescence-Like Arrest Induced by Chronic Replicational Stress
Mol. Cell. Biol., August 1, 2007; 27(15): 5336 - 5351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Xue, B. Zhou, X. Liu, Y. Heung, J. Chau, E. Chu, S. Li, C. Jiang, F. Un, and Y. Yen
Ribonucleotide Reductase Small Subunit p53R2 Facilitates p21 Induction of G1 Arrest under UV Irradiation
Cancer Res., January 1, 2007; 67(1): 16 - 21.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Liu, B. Zhou, L. Xue, J. Shih, K. Tye, W. Lin, C. Qi, P. Chu, F. Un, W. Wen, et al.
Metastasis-Suppressing Potential of Ribonucleotide Reductase Small Subunit p53R2 in Human Cancer Cells.
Clin. Cancer Res., November 1, 2006; 12(21): 6337 - 6344.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
X. An, Z. Zhang, K. Yang, and M. Huang
Cotransport of the Heterodimeric Small Subunit of the Saccharomyces cerevisiae Ribonucleotide Reductase Between the Nucleus and the Cytoplasm
Genetics, May 1, 2006; 173(1): 63 - 73.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Xu, C. Faber, T. Uchiki, J. W. Fairman, J. Racca, and C. Dealwis
Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation.
PNAS, March 14, 2006; 103(11): 4022 - 4027.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Shao, B. Zhou, A. J. Di Bilio, L. Zhu, T. Wang, C. Qi, J. Shih, and Y. Yen
A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.
Mol. Cancer Ther., March 1, 2006; 5(3): 586 - 592.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Zhang, X. An, K. Yang, D. L. Perlstein, L. Hicks, N. Kelleher, J. Stubbe, and M. Huang
Nuclear localization of the Saccharomyces cerevisiae ribonucleotide reductase small subunit requires a karyopherin and a WD40 repeat protein
PNAS, January 31, 2006; 103(5): 1422 - 1427.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Zhou, J. Shao, L. Su, Y.-C. Yuan, C. Qi, J. Shih, B. Xi, B. Chu, and Y. Yen
A dityrosyl-diiron radical cofactor center is essential for human ribonucleotide reductases
Mol. Cancer Ther., December 1, 2005; 4(12): 1830 - 1836.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Isla, C. Sarries, R. Rosell, G. Alonso, M. Domine, M. Taron, G. Lopez-Vivanco, C. Camps, M. Botia, L. Nunez, et al.
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer
Ann. Onc., August 1, 2004; 15(8): 1194 - 1203.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Lincker, G. Philipps, and M.-E. Chaboute
UV-C response of the ribonucleotide reductase large subunit involves both E2F-mediated gene transcriptional regulation and protein subcellular relocalization in tobacco cells
Nucleic Acids Res., February 27, 2004; 32(4): 1430 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Rosell, K. D. Danenberg, V. Alberola, G. Bepler, J. J. Sanchez, C. Camps, M. Provencio, D. Isla, M. Taron, P. Diz, et al.
Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., February 15, 2004; 10(4): 1318 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Shao, B. Zhou, L. Zhu, W. Qiu, Y.-C. Yuan, B. Xi, and Y. Yen
In Vitro Characterization of Enzymatic Properties and Inhibition of the p53R2 Subunit of Human Ribonucleotide Reductase
Cancer Res., January 1, 2004; 64(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-H. Weng, G. Yang, S. Weiss, and P. A. Dennery
Interaction between Heme Oxygenase-1 and -2 Proteins
J. Biol. Chem., December 19, 2003; 278(51): 50999 - 51005.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Zhou, X. Liu, X. Mo, L. Xue, D. Darwish, W. Qiu, J. Shih, E. B. Hwu, F. Luh, and Y. Yen
The Human Ribonucleotide Reductase Subunit hRRM2 Complements p53R2 in Response to UV-Induced DNA Repair in Cells with Mutant p53
Cancer Res., October 15, 2003; 63(20): 6583 - 6594.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Yao, Z. Zhang, X. An, B. Bucci, D. L. Perlstein, J. Stubbe, and M. Huang
Subcellular localization of yeast ribonucleotide reductase regulated by the DNA replication and damage checkpoint pathways
PNAS, May 27, 2003; 100(11): 6628 - 6633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.